Consumer & Prescriber Grant Program

The Consumer & Prescriber Grant Program (also going by other names, including Attorney General Prescriber Grant Program) was a grant program established with fines paid by Pfizer in the Franklin v. Parke-Davis trial for False Claims Act violations relating to off-label use of gabapentin.^[1][2]

Grant recipients

There were 24 original grant recipients.

• Oregon State University^[3]
• "Education about Heavily Marketed Drugs"^[4]
• PharmedOut^[5]
• Federation of State Medical Boards^[6]
• Robert Larner College of Medicine^[7]
• The Pew Charitable Trusts^[8]
• American Medical Association^[9]